NCI renews Moffitt’s Cancer Center Support Grant

October 18, 2006

TAMPA, Fla. – The National Cancer Institute has renewed H. Lee Moffitt Cancer Center & Research Institute’s Cancer Center Support Grant (CCSG) designating Moffitt as a comprehensive cancer center for another five years.

            “The NCI core grant review measures the quality of our research and how well we translate it to improve patient care,” says Dr. William Dalton, CEO and Center Director. “Hundreds contributed to the research efforts in the past five years and we are grateful for their dedication.”

            The NCI recognized numerous growth factors and accomplishments over the past five years that led to the renewal including:

  • Doubling of overall research funding at Moffitt
  • Recruitment of 67 new research members
  • Increase in new patients referred to Moffitt by 130%
  • Development of early phase Moffitt investigator-initiated studies
  • Increase in accruals to therapeutic and phase I, I/II and II clinical trials

In a summary the NCI review highlighted the following strengths; the expansion of basic research especially in the area of cancer prevention and control; the ability to expand further expand Moffitt’s research access with its Total Cancer Care initiative; the growth and maturation of translational/clinical research and active collaboration between bench and clinical scientists; significant attention given to early phase, investigator initiated studies; and careful recruitment of basic scientists in the areas of molecular and cancer genetics

            The CCSG supports the research, programmatic and administrative infrastructure of the cancer center. These are not normally chargeable to regular principal-investigator initiated grants.   It includes portions of senior scientific leadership, scientific program leaders, administrative infrastructure, a portion of the shared resources, selected staff investigators, planning and evaluation expenses, and most importantly, developmental funds for stimulating research, recruiting key faculty or developing new shared resources. 

Moffitt is one of only 60 NCI designated cancer centers in the country and one of 39 NCI designated comprehensive cancer centers in the country. The designation is bestowed upon institutions that have high quality research programs in basic, translational and population research and who have large community outreach and education and information programs.

About H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida on the University of South Florida campus, H. Lee Moffitt Cancer Center & Research Institute ( is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in the state of Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.